This article may need to be updated. Please update this article to reflect recent events or newly available information, and remove this template when finished.
Tarka is the brand name of an oral antihypertensive medication that combines a slow release formulation of verapamil hydrochloride, a calcium channel blocker, and an immediate release formulation of trandolapril, an ACE inhibtor. The patent, held by Abbott Laboratories, expired on June 12, 2007.
|40px||This antihypertensive-related article is a stub. You can help ssf by expanding it.|